Shares of Thermo Fisher Scientific Inc. TMO rose 1.10% to $528.96 Friday, on what proved to be an all-around positive trading ...

We recently published a list of 10 Best Affordable Dividend Stocks to Buy According to Hedge Funds. In this article, we are ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Swiss public transport company, Regionalverkehr Bern-Solothurn (RBS), made its debut in the public market on Thursday. The ...

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...

The overnight Ukrainian attack in Donetsk Oblast may have hindered Russia's ability to continue fighting in the war.

Browse in-depth TOC on HIV Diagnosis Market 332 - Tables 50 - Figures 273 - Pages Based on product type,  the HIV diagnostics ...

Solventum (NYSE:SOLV) yesterday announced fourth-quarter results that came in ahead of the consensus forecast on Wall Street.

The rising incidence of blood disorders and chronic illnesses, along with an increase in accidents and emergency care requirements, is fueling the demand for blood and blood products. Additionally, ...

The global cell separation technologies market was valued at US$ 7.1 billion in 2022 and is projected to reach over US$ 17.2 ...